How Much Is Wegovy Without Insurance? 2026 Prices

If you have searched "GoodRx Wegovy" or "cheapest semaglutide without insurance," you have run into the same maze everyone does: a sticker price north of a thousand dollars a month, a confusing stack of coupons and savings cards, and a flood of websites promising the same drug for a fraction of the cost. This guide lays out what Wegovy actually costs in 2026, which discount routes are real, and where the cheap options stop being the same medicine. Prices move, so each figure below carries the month it was checked — the NovoCare prices were re-checked in October 2026 — and you should treat every number as a range to confirm, not a quote.

One honest framing up front: Wegovy is a prescription-only drug. Its FDA label restricts it to chronic weight management in adults with obesity (or overweight plus a weight-related condition) and certain adolescents, and it requires a prescriber¹. Nothing here is medical or financial advice — it is a map of the cost landscape so you can have a sharper conversation with a clinician and your insurer.

How much is Wegovy without insurance?

Here is the short version, as of October 2026⁴:

The intro price is for new patients and runs through December 31, 2026. The rest of this guide explains each route and its catches.

The list price (and why it is rarely what anyone pays)

Wegovy's published US list price — the manufacturer's wholesale acquisition cost before any insurance or discount — has sat around $1,300–$1,350 for a 28-day supply (four weekly pens). That is the "headline" number you see in news articles, and it is real, but it is also the number the fewest people actually pay. List price matters mainly as the ceiling that every discount below is measured against.

Why so few pay it: between commercial insurance, the manufacturer savings card, the cash self-pay program, and pharmacy discount cards, most people land well under the sticker. The catch is that which discount you qualify for depends entirely on your insurance status — and the routes do not stack the way you might hope.

Route 1: Commercial insurance + the Wegovy savings card

If you have commercial (employer or marketplace) insurance that covers Wegovy, check the manufacturer's savings offer. The current terms, read October 14, 2026, advertise as little as $25 per month, subject to a maximum savings of $100 per month and other eligibility restrictions⁴. Your actual bill can be higher because of your copay, deductible and the offer's cap.

Two honest caveats:

• •It excludes government insurance. If you are on Medicare, Medicaid, TRICARE, or any federal/state plan, you are not eligible for the manufacturer savings card — that is a legal restriction, not a technicality. We map the government-coverage maze, prior authorization, and appeals in Does Insurance Cover Wegovy or Ozempic?.
• •It requires your plan to cover Wegovy in the first place. Many employer plans still exclude anti-obesity medications or gate them behind prior authorization, a documented BMI, or step-therapy. The savings card lowers your copay; it cannot create coverage that your plan does not offer.

Route 2: NovoCare self-pay (direct from the manufacturer) — the cash option

The most important recent change for cash payers is Novo Nordisk's self-pay program through NovoCare, which sells Wegovy directly to people paying out of pocket through the manufacturer's own pharmacy. As of October 2026 it prices the auto-injector pens at $199/month for a new patient's first two months (0.25 mg and 0.5 mg, an introductory rate running through December 31, 2026) and $349/month after that at every dose from 0.25 mg to 2.4 mg, with the 7.2 mg Wegovy HD pen at $399/month (see whether the 7.2 mg dose is worth the extra $50). The oral Wegovy pill is $149/month at 1.5 mg, $199 at 4 mg and $299 at 9 mg and 25 mg. Those figures are far below list and are the legitimate brand-name cash option — but they buy the medicine only, with no prescriber included. When a telehealth program advertises a lower monthly figure, check whether it is a prepaid rate before you compare: He & She MD quotes its twelve-month prepaid rate in every banner, so the figure you see advertised is not the one you pay monthly.

What you are trading for that price:

• •It is for cash payers, generally meaning you are not running it through insurance. TrumpRx lists the same prices; the Wegovy self-pay price guide sets out the terms you agree to.
• •No prescriber is included — NovoCare dispenses only, so you must arrive with a prescription. The pens are the same pre-measured, once-weekly shot we walk through in How to Inject Wegovy.
• •It is still real, FDA-approved, brand-name semaglutide — the same molecule with the same trial evidence behind it.

If you want Ozempic, the Wegovy pill and compounded prices in the same table, see semaglutide cost in every form; for Foundayo and Zepbound too, see the cheapest GLP-1 without insurance.

For many uninsured or weight-loss-excluded patients, NovoCare self-pay is the honest answer to "cheapest brand-name semaglutide without insurance." A telehealth platform can also route you to the identical NovoCare pens through its own prescriber — Rex MD does exactly that, at one flat cash price stated to hold at every dose — but the platform's own price can land above what NovoCare itself charges for the same pens, which is worth comparing before you assume "brand-name" and "cheapest brand-name" are the same claim.

Route 3: GoodRx and pharmacy discount cards

This is where expectations need recalibrating. GoodRx-type discount cards work best on generic or older drugs, where competition has driven prices down. Wegovy is a single-source brand drug with no generic, so the discounts are modest — pharmacy cash prices with a GoodRx coupon have generally hovered near or slightly below list (often still well over $1,000/month), not the dramatic cuts these cards deliver on, say, generic metformin.

Use a discount card to comparison-shop pharmacy cash prices, and to occasionally beat a bad insurance copay — but for Wegovy specifically, the manufacturer self-pay route typically beats a GoodRx coupon by a wide margin. You generally cannot combine a manufacturer savings card with a GoodRx coupon on the same fill, so pick the cheaper single route. The same logic applies to Ozempic, the diabetes-branded semaglutide; we explain why the two brands price and cover differently in Ozempic vs Wegovy. If cost has you considering Ozempic for weight loss specifically, read Ozempic dosing for weight loss first — it caps at 2 mg and isn't FDA-approved for weight, so the trade-off isn't just about price.

Route 4: Compounded semaglutide — cheaper, but read this carefully

You have seen the ads: telehealth sites offering "semaglutide" for $150–$300 a month, far below even NovoCare self-pay. This is compounded semaglutide, and it deserves an honest, non-promotional explanation, because the savings are real but so are the trade-offs. (It is also not a generic: no generic semaglutide is FDA-approved in the US.) A low headline is not the same thing as a clean record: Zealthy advertises a low compounded price, and its parent company has also drawn two FDA warning letters for how it marketed that same price — read the letters before the number. A low headline is also not always the same thing as a low total: Peter MD prices returning patients lower per month than first-timers, yet the returning tier's stated total runs higher over a comparable supply window — a reminder to add up the whole plan, not just the sticker. And a headline monthly figure is not always a monthly figure at all: SkinnyRx advertises the twelve-month rung of its price ladder without calling it a commitment, so the rate you can actually buy one month at a time is a good deal higher than the number on the page. Nor is the first number always the one you pay: Try Ageless leads its semaglutide page with a limited-time $99, below the $119–$229 range the same page prints for the doses — and the final figure only appears after the clinician review. And a monthly-looking figure is not guaranteed to be billed monthly: WellMedr leads with a semaglutide rate its own banner calls a twelve-month lock-in, then ships the plan every four weeks rather than every month, while its refund policy names a third renewal interval again — three billing intervals on one site, with no month-to-month compounded price published anywhere to check them against. If you only want sellers of the compounded version, our compounded semaglutide list puts every one we track on one page with its published price. Before you compare any of these against each other, check which plan length the advertised price assumes, check how often the plan actually bills, and check whether the seller has a second, cheaper door. A handful of sellers make that easy: Trellis Vitality prints a one-, three- and six-month table and labels which column is the month-to-month one, and at The Edit every prepay total divides back exactly into the per-month figure printed beside it — $575 for three months really is $192 a month. When a seller shows the division, you can check it; when it shows one number, you cannot. Three more shapes are worth knowing before you compare anything. A month is not always a month: Mondae prices compounded semaglutide at $87 and bills it every 28 days rather than by the calendar, which is thirteen charges a year rather than twelve, so a year costs a full cycle more than the monthly figure implies. An advertised rate is not always a rate: Alinwell advertises $149 a month across its whole site, and its own checkout labels that figure a first-month discount with $249 struck through beside it, and MEDGm's $179 is a welcome coupon applied automatically — remove it and the price panel rewrites itself to $299. And a cheap rate is not always a committed one: Lean Meds sells compounded semaglutide at $79 a month on a one-month plan with no prepay, and states the price does not change as your dose increases, though the $49 its homepage leads with is the twelve-month tier.

Look at enough online sellers and the same few pricing patterns keep turning up. Learn to spot them and you will avoid most surprises at checkout. A price can be flat by dose and still not be the price you are shown first: bmiMD charges the same whatever your dose, but its pricing block opens on the three-month tab rather than the monthly one. A drug price can be real and still not be the bill: Collective's medication charge is the lowest we found and a mandatory annual membership sits underneath it, unmentioned in the headline. A rate can be described as permanent and be a prepay: Rx.com's "for life" banner quotes its 12-month rate, not the month-to-month price. A published figure can be a floor rather than a price: RX Bella quotes "from" figures that match none of its own product cards. A fee can exist only in the terms: Idgie Health publishes the amount billed on day one at every rung, then describes a recurring membership fee the pricing page never mentions. And a month is not always a month: Prime Doctor RX bills every four weeks and labels every price per month, which is thirteen charges a year.

Three of the ten are worth knowing for the opposite reason. No BS RX names four dispensing pharmacies with street addresses and commits in writing to not advertising an intro rate that later climbs, and its own arithmetic backs the promise. Renlo Health's headline is the actual monthly rate, with the prescribing physician and the dispensing pharmacy both named. And Science & Co states in its own footer that it is not a compounding facility — a question most sellers never raise — though it does not name the pharmacy that is. The tenth, Edessa, publishes a clean three-rung table on each product page behind a front page whose cards all quote the longest commitment on it.

Compounded drugs are mixed by a pharmacy rather than manufactured and FDA-approved as a finished product. During 2023–2024, semaglutide's official shortage allowed widespread compounding under the FDA's shortage rules. That shortage was resolved, and the FDA set deadlines after which large-scale compounding of semaglutide copies was no longer permitted under the shortage exemption. The practical situation as of June 2026 is messier than the ads imply:

• •Regulatory status is narrow and shifting. With semaglutide off the shortage list, routine "mass" compounding of straight copies is restricted. Some compounding continues under specific, patient-tailored exemptions (for example, a documented clinical need for a different formulation), but a blanket cheap-copy market is not on the same legal footing it was during the shortage. We trace the full regulatory timeline in is compounded semaglutide still legal in 2026?.
• •It is not FDA-approved, and not the trial product. The robust efficacy and cardiovascular evidence for semaglutide — the STEP 1 weight-loss trial² and the SELECT cardiovascular-outcomes trial³ — was generated with brand-name Novo Nordisk semaglutide, not compounded versions. Compounded products are not tested for that efficacy, and quality, dosing accuracy, and sterility depend entirely on the compounding pharmacy.
• •The FDA has flagged safety concerns, including dosing errors (patients self-measuring from vials and overdosing) and the use of unapproved salt forms (semaglutide sodium / semaglutide acetate) that are not the same as the approved active ingredient.

None of this means every compounded product is dangerous, and many patients use them. But "cheaper" here means stepping outside the FDA-approved supply chain and the evidence base — a genuine gray-market trade-off, not a free lunch. If a price looks far too good and the site is vague about whether it is brand-name or compounded, that is your signal to ask directly — and to check which pharmacy is actually behind the vial, since most providers never say.

Putting it together: which route is actually cheapest for you?

There is no single "cheapest" — it depends on your insurance status, and on whether the figure you are comparing is a month at all: some compounded sellers quote a monthly-looking figure for a plan billed every four weeks, which is 13 charges a year rather than twelve. To put real numbers on your own situation, our Wegovy & Ozempic cost calculator estimates your monthly and annual out-of-pocket cost by payment route (and adds any telehealth membership fee):

• •Commercial insurance that covers Wegovy: check the savings offer — as little as $25 per month, with savings capped at $100 per month and eligibility restrictions. Compare your actual covered cost.
• •Uninsured / weight-loss-excluded plan, want brand-name: NovoCare self-pay pens ($199/month for a new patient's first two fills, then $349/month) → the legitimate cash option.
• •Government insurance (Medicare/Medicaid/TRICARE): not eligible for the commercial savings card. Coverage depends on the benefit and prescribed use. Eligible Medicare beneficiaries should check the separate GLP-1 Bridge, which offers included products at $50/month through December 2027^5,6.
• •Lowest possible price: compounded semaglutide ($150–$300) → cheapest, but not FDA-approved, with the regulatory and quality caveats above.

A practical reminder that affects long-term cost: semaglutide manages weight rather than curing it. In the STEP 1 trial extension, people who stopped regained a large share of the lost weight within about a year, so this tends to be ongoing therapy — budget for the long run, not a single month. We unpack that in What Happens If You Stop Semaglutide?. If the recurring price has you asking whether the whole thing pencils out, we weigh the ~15% loss against the indefinite cost in Is Wegovy worth it?. If you are weighing the daily-tablet route as a cost or convenience alternative, see Oral vs Injectable Semaglutide, our look at the oral tablet, Rybelsus, and — for the new obesity-dose tablet specifically — what the oral Wegovy pill costs.

The honest bottom line

Wegovy's list price is high, but it is rarely the price you pay. With commercial coverage, the manufacturer savings card usually wins; without it, NovoCare's self-pay pens are the legitimate cash route; GoodRx-type cards help you comparison-shop but rarely beat those on a brand drug; and compounded semaglutide is the cheapest of all — at the cost of stepping outside FDA approval and the clinical-trial evidence. Verify any number before you commit (the prices here were checked between June and October 2026), confirm whether a product is brand-name or compounded, and run the decision past a prescriber. If you'd rather buy online, we map the legitimate telehealth and manufacturer routes — and the membership-fee stacking to watch — in the best places to get Wegovy & Ozempic online. For where to actually start, our best semaglutide providers guide shows what each program charges and what that price covers, and if the only thing you care about is the number, we sort every provider we track cheapest-first in the cheapest semaglutide, in price order, flagging which headline figures are intro rates, memberships or partial doses; both lists, and how they differ, sit on our provider guides hub. Want to put two specific programs head to head yourself, with the pharmacy-disclosure facts alongside the price? Our comparison table lines up every provider we track and lets you pick any two directly. That flagging is not academic — Lemonaid bills a mandatory membership underneath every medication price it advertises, Care Bare Rx quotes a floor and holds the per-dose numbers back until you are inside the intake, Breeze Meds leads with a floor too, and Effecty is one of the few that publishes brand-name cash prices next to its compounded ones so you can see what the discount actually buys. Our pillar Semaglutide: How It Works, Results & Side Effects covers what the drug does once you are on it. If you are weighing a guided, coach-supported program against a leaner prescription route, our honest provider reviews price each one all-in — see Calibrate, Ro for Wegovy, and Noom.

One provider worth checking against any of these is SnagRx, which holds one price at every dose and publishes its whole commitment ladder — though its headline figure is the twelve-month prepay rung rather than the recurring one.